Foamix Pharmaceuticals Ltd Quick Ratio (FOMX) starting from the fourth quarter 2019 to fourth quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Foamix Pharmaceuticals Ltd   (FOMX)

Foamix Pharmaceuticals Ltd 's Quick Ratio

FOMX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2019, Quick Ratio fell to 2.92 below Foamix Pharmaceuticals Ltd average.

Within Legal Cannabis industry only one company has achieved higher Quick Ratio in fourth quarter 2019. While Quick Ratio total ranking in the fourth quarter 2019 has deteriorated compared to the prior quarter from 510 to 993.

Explain Quick Ratio?
How much Cash & cash equivalents FOMX´s has?
What are FOMX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FOMX Quick Ratio (Dec 31 2019)
Q4		 (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2		 (Mar 31 2019)
Q1		 (Dec 31 2018)
Q4
Y / Y Current Liabilities Change 131.47 % 43.29 % -9.47 % -16.57 % 80.26 %
Y / Y Cash & cash equivalent Change -26.47 % -26.89 % 89.78 % 73.51 % 28.77 %
Quick Ratio MRQ 2.92 5.84 5.12 9.06 9.18
FOMX's Total Ranking # 993 # 510 # 558 # 329 # 131
Seq. Current Liabilities Change 91.56 % -5.39 % 51.34 % -15.61 % 18.59 %
Seq. Cash & cash equivalent Change -4.42 % 8.07 % -14.52 % -16.73 % -4.96 %



Quick Ratio fourth quarter 2019 Company Ranking
Within: No.
Legal Cannabis Industry # 2
Consumer Non Cyclical Sector # 18
Overall Market # 993


Quick Ratio Statistics
High Average Low
22.95 9.31 2.5
(Jun 30 2016)   (Dec 31 2019)




Financial Statements
Foamix Pharmaceuticals Ltd 's Current Liabilities $ 25 Millions Visit FOMX's Balance sheet
Foamix Pharmaceuticals Ltd 's Cash & cash equivalent $ 72 Millions Visit FOMX's Balance sheet
Source of FOMX's Sales Visit FOMX's Sales by Geography


Cumulative Foamix Pharmaceuticals Ltd 's Quick Ratio

FOMX's Quick Ratio for the trailling 12 Months

FOMX Quick Ratio

 (Dec 31 2019)
12 Months		 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months		 (Mar 31 2019)
12 Months		 (Dec 31 2018)
12 Months
Y / Y Current Liabilities TTM Growth 32.32 % 13.32 % -1.09 % 35.14 % 97 %
Y / Y Cash & cash equivalent TTM Growth 4.88 % 23.47 % 42.15 % -6.5 % -20.49 %
Quick Ratio TTM 4.96 7.03 8.33 7.3 6.26
Total Ranking TTM # 4533 # 4324 # 4186 # 4259 # 4346
Seq. Current Liabilities TTM Growth 30.37 % 9.21 % -3.26 % -3.93 % 11.65 %
Seq. Cash & cash equivalent TTM Growth -7.99 % -7.87 % 10.33 % 12.14 % 8.32 %

Quick ratio ranking by company, industry and sector >> Back to FOMX Financial Strength Comparisons >> Go to Compare FOMX Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q4 2019 to $24.81 millions, cumulative Quick Ratio decreased to 4.96 below the Foamix Pharmaceuticals Ltd average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Legal Cannabis industry 20 other companies have achieved higher Quick Ratio than Foamix Pharmaceuticals Ltd . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2019 from 4324 to 4533.

Explain Quick Ratio?
How much Cash & cash equivalents FOMX´s has?
What are FOMX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Legal Cannabis Industry # 21
Consumer Non Cyclical Sector # 168
Within the Market # 4533


trailing twelve months Quick Ratio Statistics
High Average Low
14.87 8.27 4.55
(Jun 30 2016)   (Dec 31 2019)




Companies with similar Quick Ratio in the quarter ending Dec 31 2019, within Legal Cannabis Industry Quick RatioDec 31 2019 MRQ Cash & cash equivalentDec 31 2019 MRQ Current Liabilities
Im Cannabis Corp   5.34 $ 10.744  Millions$ 2.013  Millions
Cronos Group Inc   4.53 $ 1,506.040  Millions$ 332.461  Millions
Foamix Pharmaceuticals Ltd   2.92 $ 72.346  Millions$ 24.809  Millions
American Cannabis Company Inc   2.91 $ 0.945  Millions$ 0.324  Millions
Natural Alternatives International Inc  1.76 $ 25.040  Millions$ 14.250  Millions
Usana Health Sciences Inc   1.56 $ 234.830  Millions$ 150.510  Millions
Pure Harvest Corporate Group Inc   1.29 $ 1.665  Millions$ 1.290  Millions
Niagen Bioscience Inc   1.25 $ 18.812  Millions$ 15.063  Millions
Tilray Brands Inc   1.05 $ 96.791  Millions$ 92.427  Millions
Mannatech Inc  1.01 $ 25.705  Millions$ 25.495  Millions
Hanjiao Group Inc   0.88 $ 29.186  Millions$ 33.204  Millions
Mediwound Ltd   0.70 $ 7.242  Millions$ 10.373  Millions
Quanta Inc.  0.66 $ 0.467  Millions$ 0.705  Millions
4front Ventures Corp   0.65 $ 11.578  Millions$ 17.880  Millions

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.